My reading of that report is that post Phase 1 the target is 4 x (ie $2) and post Phase 2 the target is over $7.
Both price targets assume success at each Phase and depending on continued pace of trials the $7 target may be end of 2023.
Ann: SRC Approves Commencement Of Fourth And Final Cohort Dosing, page-7
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
73.0¢ |
Change
0.010(1.39%) |
Mkt cap ! $93.50M | |||
| Open | High | Low | Value | Volume |
| 71.0¢ | 73.5¢ | 71.0¢ | $88.24K | 122.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17875 | 71.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.5¢ | 762 | 1 |
View Market Depth
| Last trade - 15.53pm 09/10/2024 (20 minute delay) ? |
| AGN (ASX) Chart |